The significant differences in expression between precancerous and benign tumors (PERP: 72.8% vs. 26.6%, p = 0.001; Akt: 37.7% vs. 0.9%, p = 0.001) further highlight their involvement in the transition from benign to malignant neoplasms. This evidence concerns the gene PERP and cancer.